By: Adhella Menur As a member of the INA-RESPOND Science team, I am thrilled with the acceptance of the first publication from our HIV study, entitled “A Prospective Observational Cohort Study of HIV Infection in Indonesia: Baseline Characteristics and One-Year Mortality” in the BMC Infectious Dis-eases journal. This paper provides valuable evidence for Indonesia and
Read moreBy: Meity Siahaan, Dedy Hidayat On December 4-5, 2024, a delegation from the Indonesian Ministry of Health (MoH) visited the United States National Institutes of Health (NIH) to strengthen existing collaborations and explore new opportunities in health research. This visit was an important step in strengthening bilateral cooperation in clinical research and capacity building between
Read moreBy: Aaron Neal INA-RESPOND has much to celebrate over the past year, and much to be excited for in 2025. Highlights from 2024 include the completion of the InVITE study, presentations at the annual Re-PORT tuberculosis (TB) meeting in Brazil, and the acceptance of key publications from HIV study (INA-PROACTIVE) and TB study (TRIPOD). Despite
Read moreBy: INA-RESPOND NSC Members and Secretariat New Year, New Hope! To move forward with strength, we must first reflect on the journey that has brought us here. Over the past 14 years, INA-RESPOND has grown into a center of excellence in infectious disease research in Indonesia. This achievement would not have been possible with-out the
Read more
Most Commented